AWA
IDXX icon

Arkadios Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Arkadios Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Sell
884
-336
-28% -$188K 0.01% 1165
2026
Q1 		$686K Buy
1,220
+176
+17% +$113K 0.01% 962
2025
Q4 		$706K Sell
1,044
-81
-7% -$55.2K 0.01% 856
2025
Q3 		$719K Buy
1,125
+370
+49% +$225K 0.02% 782
2025
Q2 		$405K Buy
+755
New +$361K 0.01% 935
2021
Q3 		– Sell
-3
Closed -$1K – 1946
2021
Q2 		$1K Buy
+3
New +$1.66K ﹤0.01% 1903

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Arkadios Wealth Advisors's IDXX Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 28% in Q2 2026, selling an estimated $188K and leaving 884 shares worth $465K. The position accounts for 0.01% of the portfolio, ranked #1165.

Arkadios Wealth Advisors first reported a position in IDXX in Q2 2021 and has held it in 6 quarters since. The position peaked at $719K in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Arkadios Wealth Advisors held 884 shares of Idexx Laboratories worth $465K as of Q2 2026.
  • Arkadios Wealth Advisors sold 336 Idexx Laboratories shares in Q2 2026, an estimated $188K.
  • Idexx Laboratories made up 0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1165 holding.
  • Arkadios Wealth Advisors first reported a position in Idexx Laboratories in Q2 2021 and has held it in 6 quarters since.
  • Arkadios Wealth Advisors's Idexx Laboratories position peaked at $719K in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.